West Pharmaceutical Services WST Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $872.3M+13.8% | $844.9M+21.0% | $805M+7.5% | $804.6M+7.7% | $766.5M+9.2% | ||
| $543.1M+10.3% | $548.5M+17.7% | $501.1M+5.5% | $510.3M+5.8% | $492.6M+4.3% | ||
| $329.2M+20.2% | $296.4M+27.8% | $303.9M+11.1% | $294.3M+11.2% | $273.9M+19.1% | ||
| 37.7%+2.0pp | 35.1%+1.9pp | 37.8%+1.2pp | 36.6%+1.1pp | 35.7%+3.0pp | ||
| $19.7M+3.1% | $15.8M-3.1% | $21.8M+17.8% | $17.1M+10.3% | $19.1M+9.1% | ||
| $117.6M+22.6% | $99.5M+13.1% | $107M+25.4% | $102.7M+23.0% | $95.9M+15.5% | ||
| $179.1M+16.5% | $177.1M+65.5% | $156.6M-1.9% | $167.6M+3.9% | $153.7M+21.8% | ||
| 20.5%+0.5pp | 21%+5.6pp | 19.5%-1.9pp | 20.8%-0.8pp | 20.1%+2.1pp | ||
| $2.6M+2,500% | $1.9M+375% | —— | $200K-71.4% | $100K-93.3% | ||
| -$200K0.0% | -$200K0.0% | -$400K+96.5% | -$200K-106% | -$200K-108% | ||
| $180.1M+14.7% | $180.1M+63.0% | $161.5M-2.1% | $171.9M+4.5% | $157M+22.0% | ||
| $32.2M+6.6% | $44.7M+85.5% | $33.3M-9.5% | $34M+4.9% | $30.2M+37.9% | ||
| $154M+16.8% | $138.8M+54.6% | $132.1M+1.5% | $140M+2.9% | $131.8M+18.4% | ||
| 17.7%+0.5pp | 16.4%+3.6pp | 16.4%-1.0pp | 17.4%-0.8pp | 17.2%+1.3pp | ||
| $2.15+18.1% | $1.92+56.1% | $1.82+2.2% | $1.92+3.8% | $1.82+20.5% | ||
| $225.3M+15.5% | $222.3M+51.2% | $203M+1.8% | $210.6M+4.5% | $195.1M+18.2% | ||
| 25.8%+0.4pp | 26.3%+5.3pp | 25.2%-1.4pp | 26.2%-0.8pp | 25.5%+1.9pp | ||
| $179.1M+16.5% | $177.1M+65.5% | $156.6M-1.9% | $167.6M+3.9% | $153.7M+21.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is West Pharmaceutical Services's revenue?
- West Pharmaceutical Services (WST) generated $3.3B in revenue over the trailing twelve months, up 12.4% year over year.
- Is West Pharmaceutical Services profitable?
- West Pharmaceutical Services reported $564.9M in net income over the trailing twelve months, a 17.0% net margin.
- What are West Pharmaceutical Services's profit margins?
- Gross margin is 36.8% and operating margin is 20.5%, with a 17.0% net margin.
- What is West Pharmaceutical Services's earnings per share?
- West Pharmaceutical Services's diluted EPS over the trailing twelve months is $7.81.
- Where does West Pharmaceutical Services's income statement data come from?
- Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
